These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22676354)

  • 1. Reasons physicians do not recommend and patients refuse adjuvant chemotherapy for stage III colon cancer: a population based chart review.
    El Shayeb M; Scarfe A; Yasui Y; Winget M
    BMC Res Notes; 2012 Jun; 5():269. PubMed ID: 22676354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why adjuvant chemotherapy for stage III colon cancer was not given: Reasons for non-recommendation by clinicians or patient refusal.
    Gilbar P; Lee A; Pokharel K
    J Oncol Pharm Pract; 2017 Mar; 23(2):128-134. PubMed ID: 26692241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake and tolerance of adjuvant chemotherapy in early stage NSCLC patients in Alberta, Canada.
    Winget M; Fleming J; Li X; Gao Z; Butts C
    Lung Cancer; 2011 Apr; 72(1):52-8. PubMed ID: 20708293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004.
    Cree M; Tonita J; Turner D; Nugent Z; Alvi R; Barss R; King C; Winget M
    Clin Colorectal Cancer; 2009 Jul; 8(3):141-5. PubMed ID: 19632928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment.
    Winget M; Hossain S; Yasui Y; Scarfe A
    Cancer; 2010 Oct; 116(20):4849-56. PubMed ID: 20578180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer.
    Krzyzanowska MK; Regan MM; Powell M; Earle CC; Weeks JC
    J Am Coll Surg; 2009 Feb; 208(2):202-9. PubMed ID: 19228531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada.
    Eldin NS; Yasui Y; Scarfe A; Winget M
    Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e9-17. PubMed ID: 21802914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients.
    Mahoney T; Kuo YH; Topilow A; Davis JM
    Arch Surg; 2000 Feb; 135(2):182-5. PubMed ID: 10668878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of surgery and consult with an oncologist for adjuvant chemotherapy in early stage NSCLC patients in Alberta, Canada.
    Winget M; Stanger J; Gao Z; Butts C
    J Thorac Oncol; 2009 May; 4(5):629-34. PubMed ID: 19276835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
    Keating NL; Landrum MB; Klabunde CN; Fletcher RH; Rogers SO; Doucette WR; Tisnado D; Clauser S; Kahn KL
    J Clin Oncol; 2008 May; 26(15):2532-7. PubMed ID: 18487570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in Delayed Time to Adjuvant Chemotherapy and Disease-Specific Survival in Stage III Colon Cancer Patients.
    Becerra AZ; Aquina CT; Mohile SG; Tejani MA; Schymura MJ; Boscoe FP; Xu Z; Justiniano CF; Boodry CI; Swanger AA; Noyes K; Monson JR; Fleming FJ
    Ann Surg Oncol; 2017 Jun; 24(6):1610-1617. PubMed ID: 27738848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons for delay in timely administration of adjuvant chemotherapy for patients with stage III colon cancer: a multicentre cohort study from the McGill University Department of Oncology.
    Elkrief A; Redstone G; Petruccelli L; Ali A; Thomas D; Fernandez M; Rousseau C; Aleynikova O; Anderson D; Ghitulescu G; Vasilevsky CA; Dalfen R; Langleben A; Liberman S; Kavan P; Alcindor T
    BMJ Open Qual; 2021 Mar; 10(1):. PubMed ID: 33685857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada.
    Lima IS; Yasui Y; Scarfe A; Winget M
    Cancer; 2011 Aug; 117(16):3833-40. PubMed ID: 21319156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practice Variation in the Adjuvant Treatment of Colon Cancer in the Netherlands: A Population-based Study.
    Keikes L; Koopman M; Lemmens VEPP; VAN Oijen MGH; Punt CJA
    Anticancer Res; 2020 Aug; 40(8):4331-4341. PubMed ID: 32727761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
    Ejaz A; Casadaban L; Maker AV
    J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the outcomes of adjuvant chemotherapy for colon cancer prescribed by physicians in different disciplines: a population-based study in Taiwan.
    Hsieh CI; Kuo RN; Liang CC; Tsai HY; Chung KP
    BMJ Open; 2018 Dec; 8(12):e021341. PubMed ID: 30567819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of adjuvant chemotherapy for stage II and III colon cancer in France and Italy.
    Bouvier AM; Minicozzi P; Grosclaude P; Bouvier V; Faivre J; Sant M
    Dig Liver Dis; 2013 Aug; 45(8):687-91. PubMed ID: 23428703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients.
    Hsieh MC; Thompson T; Wu XC; Styles T; O'Flarity MB; Morris CR; Chen VW
    Cancer Med; 2016 May; 5(5):871-80. PubMed ID: 26773804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient age and cancer treatment decisions. Patient and physician views.
    Kutner JS; Vu KO; Prindiville SA; Byers TE
    Cancer Pract; 2000; 8(3):114-9. PubMed ID: 11898135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.
    Benson AB; Schrag D; Somerfield MR; Cohen AM; Figueredo AT; Flynn PJ; Krzyzanowska MK; Maroun J; McAllister P; Van Cutsem E; Brouwers M; Charette M; Haller DG
    J Clin Oncol; 2004 Aug; 22(16):3408-19. PubMed ID: 15199089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.